Sabera Nazneen Rahman CBE FMedSci[2] is a geneticist who specialises in cancer research[3] and is a non-executive director for AstraZeneca.
[4][5] Rahman qualified in medicine from University of Oxford in 1991, and completed a PhD in Molecular Genetics in 1999 on the Wilms' tumor susceptibility gene FWT1.
She was head of Genetics and Epidemiology at the Institute of Cancer Research, based at the Sir Richard Doll Building in Sutton.
[10] Rahman held a clinical role as head of the cancer genetics service at The Royal Marsden and St George's Hospital in south west London.
[1] Rahman resigned from her position following in October 2018 following upholding on independent investigation of a complaint of systematic bullying spanning 15 years from 44 of her current and former staff and students .